Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with SRPT: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
SRPT
Sarepta Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
SRPT
Sarepta Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LLY
with
SRPT
Uncorrelated: r 0.12 · 501D.
No shared co-movers.
LLY, solid
SRPT, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,379.92
▼
−2.68%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
SRPT
Sarepta Therapeutics, Inc.
Change
17.85
▼
−6.00%
Regular session
Nov 5 '26
Mkt cap
$2.0B
Revenue
$401M
Q2 FY26
Revenue
$2.2B
FY25
vs
Compare
Regular session
Nov 5 '26
LLY
ELI Lilly & Co
vs
SRPT
Sarepta Therapeutics, Inc.
1,379.92
▼
−2.68%
Price
17.85
▼
−6.00%
$1.3T
Mkt cap
$2.0B
Q3 FY26
$24.4B
Revenue
$401M
Q2 FY26
FY25
$65.2B
Revenue
$2.2B
FY25
Change
Change
LLY
1,379.92
▼
−2.68%
vs
SRPT
17.85
▼
−6.00%
Regular session
Nov 5 '26